New Delhi: The Prime Minister, Narendra Modi, interacted with the Chief Ministers to review the COVID-19 scenario.Union Home Minister spoke concerning the latest enhance in COVID-19 circumstances in some ...
The authorities is contemplating bringing a coverage to advertise manufacturing of patented medication in India, Union Chemicals and Fertilisers Minister Mansukh Mandaviya stated on Friday. Speaking on the curtain ...
Representative ImageNew Delhi: India’s COVID-19 vaccination protection has exceeded 187.07 (1,87,07,08,111) crore. This has been achieved by 2,28,80,254 classes. So far, greater than 2.53 (2,53,87,677) crore adolescents have been ...
New Delhi: India’s COVID-19 vaccination protection has exceeded 186.90(1,86,90,56,607) crore. This has been achieved via 2,28,31,901 classes.So far, greater than 2.50 Cr (2,50,83,940) adolescents have been administered with the ...
India’s COVID-19 vaccination protection has exceeded 183.53 (1,83,53,90,499) crore. This has been achieved by 2,18,49,698 periods.COVID-19 vaccination for the age group 12-14 years was began on March 16, 2022. ...
The exterior affairs ministry (MEA) has urged the well being ministry to introduce booster Covid-19 doses for travellers to worldwide locations, significantly Europe, who took their second (remaining) dose ...
Prime Minister Narendra Modi on Saturday mentioned yoga is uniting the world in pursuit of good well being and wellness as he lauded the Indian embassy's "nice effort" in ...
By Prabhat Prakash New Delhi: Despite the temporary decline in TB notifications noticed across the months equivalent to India’s two main COVID-19 waves, the National Tuberculosis Elimination Programme (NTEP) ...
(*33*)India’s COVID-19 vaccination protection has exceeded 181.56 (1,81,56,01,944) crore. This has been achieved by means of 2,14,38,677 classes.COVID-19 vaccination for the age group 12-14 years began on March 16, ...
Hyderabad: Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has mentioned Phase-1 medical trials of its ...